Similarly, microvesicles produced by hypoxic lung carcinoma and CML cells attenuated NK cell antitumor responses in vitro, presumably via transforming growth factor beta 1 (TGF-β1) and miR23a [98]. The gene discussed is TGFB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.